AGENUS INC 8-K

What Happened
Agenus Inc. (AGEN) filed an 8-K (Item 5.02) reporting that, effective January 8, 2026, the Board appointed Dr. Garo Armen (Chairman and CEO, age 72) to serve as interim Chief Financial Officer and Principal Financial Officer, and appointed Austin Charette (Senior Director, Financial Reporting and Compliance, age 37) to serve as Principal Accounting Officer. The report was signed and filed on January 14, 2026.

Key Details

• Appointments effective January 8, 2026; 8-K filed January 14, 2026 (Item 5.02).
• Dr. Garo Armen: co‑founder (1994), Chairman & CEO, age 72; named interim CFO/Principal Financial Officer; continues to receive base salary and any potential bonus payments in Agenus stock rather than cash. No new or modified compensation arrangements tied to this designation.
• Austin Charette: joined Agenus in August 2017; Senior Director, Financial Reporting and Compliance; named Principal Accounting Officer; prior experience at Deloitte & Touche LLP (2013–2017). No new or modified compensation arrangements tied to this designation.
• Neither appointee has family relationships with company officers/directors, and neither is party to related‑party transactions required to be disclosed under Item 404(a) of Regulation S‑K.

Why It Matters
These appointments consolidate key finance and accounting responsibilities during a transition period: the CEO is serving as interim CFO while a senior internal reporting leader becomes Principal Accounting Officer. For investors, this affects corporate governance and who is responsible for financial reporting and controls. The filing shows no new compensation deals tied to the roles, and the changes are presented as temporary/interim (for the CFO), which may imply continuity in reporting but is a point to monitor in future disclosures.